CN1129447C - Anshen pill-treating cardio-cerebral angiopathy - Google Patents

Anshen pill-treating cardio-cerebral angiopathy Download PDF

Info

Publication number
CN1129447C
CN1129447C CN 01102281 CN01102281A CN1129447C CN 1129447 C CN1129447 C CN 1129447C CN 01102281 CN01102281 CN 01102281 CN 01102281 A CN01102281 A CN 01102281A CN 1129447 C CN1129447 C CN 1129447C
Authority
CN
China
Prior art keywords
medicine
present
grams
pill
cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 01102281
Other languages
Chinese (zh)
Other versions
CN1304771A (en
Inventor
白玛加措
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zahi Wan Fagafaga
Original Assignee
白玛加措
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 白玛加措 filed Critical 白玛加措
Priority to CN 01102281 priority Critical patent/CN1129447C/en
Publication of CN1304771A publication Critical patent/CN1304771A/en
Application granted granted Critical
Publication of CN1129447C publication Critical patent/CN1129447C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present inventiondiscloses a Tibetan medicine for treating cardiovascular and cerebrovascular diseases, which is prepared from 6 to 12 of wide spine date, 6 to 12 of angelica, 6 to 12 of chiese eaglewood wood, 6 to 12 of short common corydalis, 6 to 12 of nutmeg, 6 to 12 of phyllanthus emblica l, 6 to 12 of longfruit speedwell herbs, 6 to 12 of garlic, 6 to 12 of medicine terminalia fruit, 6 to 12 of raisin and 0.1 to 0.8 of cinnabar. The present invention has the action of palpitation relief, tranquilization, qi invigorating and pressure reduction, and is used for pathological symptoms, such as nervous headache, headache caused by high blood pressure and low blood pressure, migraine, insomnia, flusteredness, etc. The present invention can also improve the blood circulation oof a human body and promote the blood supply of the cerebrum and cardiac muscles.

Description

The medicine of treatment cardiovascular and cerebrovascular disease
The present invention relates to a kind of Tibetan medicine for the treatment of cardiovascular and cerebrovascular disease, specifically is the conventional medicament that is prepared from the Tibet authentic medicinal herbs, belongs to drug world.
Cardiovascular and cerebrovascular disease is various because of its pathogenic factors, pathomechanism is complicated, the treatment is very thorny, and is referred to as one of human main causes of death by modern medicine.The modern adds the impetus that new and high technology is powerful to the modern medical service cause along with living standard improves constantly, and human average life prolongs day by day.But because the continuous quickening of aged tendency of population and work, rhythm of life, the prevalence of cardiovascular and cerebrovascular disease, M ﹠ M but have the trend that rises year by year, and in those undertake the responsibility the heaviest age group to work, society and family, cardiovascular and cerebrovascular disease is one of early stage main causes of death especially, human beings'health and life-span in serious threat, press for the work of strengthening prevention and treatment cardiovascular and cerebrovascular disease.
Having much though treat the medicine of cardiovascular disease in the market, is not that drug effect does not reach requirement, is exactly the health that side effect is endangering human body greatly and from another point of view.And Tibetan medicine not only has original curative effect to treating this type of disease, and the pharmaceutical compositions of Tibetan medicine special formula rule and process of preparing Chinese medicine processing technique and pure natural, property of medicine gentleness, substantially have no side effect and untoward reaction, avoided of the side effect of most of cardiovascular patients because of needing long-term prescription to cause.
Tibetan medicine's pharmacy is that Tibetan people is under these special natural conditions and living environment of Qinghai-Tibet Platean, constantly sum up the experience of struggling with various diseases, and gather materials on the spot Tibet plateau abundant move, plant, mineral are as the material of preventing and curing diseases, and by constantly the enriching, improve and improve of the Tibetan medicine and pharmacology scholars successive dynasties, different schools, progressively of forming of development has complete theoretical system, abundant diagnosis and treatment content and the medicine of national minorities of distinct national characters.Be Tibetan people in 2,000 years of development processes constantly and the various diseases wisdom crystallization of struggling.
Over more than 2,000 year, the Tibetan medicine and pharmacology schoolmate phase is applied to clinical, accumulated the abundant experience of preventing and curing diseases, it has not only made major contribution for the physical and mental health of area people of all nationalities of Tibetan with multiplying and being prosperous in the past, nowadays in the develop rapidly of modern medical service technology, human growing interest health under the new situation, Tibetan medicine and pharmacology still in a lot of treatment of diseases of modern times especially in some difficult miscellaneous diseases such as aspects such as cardiovascular and cerebrovascular diseases, demonstrated the therapeutic effect that makes the admiration of modern medicine circle.
The inventor rises year by year at prevalence, the M ﹠ M of present cardiovascular and cerebrovascular disease, the trend that its hazardness spreads day by day, make full use of Tibetan medicine and pharmacology in the original curative effect that is had aspect this type of disease of treatment, based on Tibetan medicine and pharmacology scientific principle opinion, draw the elite of Tibetan medicine and pharmacology successive dynasties well-known doctor's classics, treasured book, monograph, in conjunction with oneself abundant for many years clinical practice experience, cardiovascular and cerebrovascular disease does painstaking research, and select the genuine pure natural medical material of Tibet plateau prescription for use, follow the special process of preparing Chinese medicine processing technique of Tibetan medicine, developed the Anshen Wan of treatment cardiovascular and cerebrovascular disease.
Therefore, the object of the invention provides a kind of medicine Anshen Wan for the treatment of cardiovascular and cerebrovascular disease.
The composition of medicine of the present invention is as follows by weight:
GUANGSUANZAO 6-12, Radix Angelicae Sinensis 6-12, Lignum Aquilariae Resinatum 6-12, Herba Corydalis 6-12, Semen Myristicae 6-12, Fructus Phyllanthi 6-12, Herba Veronicae Ciliatae 6-12, Bulbus Allii 6-12, Fructus Chebulae 6-12, dried Fructus Vitis viniferae 6-12, Cinnabaris 0.1-0.8.
Said medicine dosage form of the present invention is the watered pill and capsule, the heavy 2.5g of per 10 balls of pill.
The preparation method of medicine of the present invention is as follows:
Form ten simply by said medicine, except that Cinnabaris, Bulbus Allii, all the other are ground into fine powder altogether, sieve, and with Cinnabaris, Bulbus Allii dispel poison, processing and porphyrize, with above-mentioned powder facing-up, sieve, and mixing directly incapsulates with water pill or with medicated powder, promptly.
Bolus of drug of the present invention is the watered pill of rufous, and capsule 's content is the light yellowish brown powder, gas perfume (or spice), and bitter in the mouth, sweet.
The function of medicine of the present invention with curing mainly is: relieving palpitation, calm the nerves, QI invigorating, blood pressure lowering.Be used for headache that nervous headache, blood pressure just cause, migraine, insomnia, disease such as nervous, and can improve the blood circulation of human body, promote the blood supply of brain and cardiac muscle.
The instructions of taking of medicine of the present invention is: oral, 1~2 time on the one, one time 5 ball pulverizes into the fine powder warm boiled water with medicine.
Medicine of the present invention has made full use of the original advantage of Tibetan medicine, and is formulated meticulously.The cardiovascular patient that is fit to all ages and classes, different body constitution is taken for a long time, is collection good efficacy and safety and Tibetan medicine new product all over the body.Through preliminary clinical and observation of curative effect, medicine of the present invention has shown good effect to the treatment of cardiovascular disease such as hypertension, hyperlipidemia, coronary heart disease, arrhythmia, cardiac insufficiency, myocardial ischemia and circulation be not smooth, find no any untoward reaction, firmly get vast medication patient's welcome, and become the popular Tibetan medicine kind that present Tibetan area patient seeks medical advice and medicine.
Embodiment 1
Prescription:
GUANGSUANZAO 9.95 grams, Radix Angelicae Sinensis 9.95 grams, Lignum Aquilariae Resinatum 9.95 grams, Herba Corydalis 9.95 grams, Semen Myristicae 9.95 grams, Fructus Phyllanthi 9.95 grams, Herba Veronicae Ciliatae 9.95 grams, Bulbus Allii 9.95 grams, Fructus Chebulae's 9.95 grams, dried Fructus Vitis viniferae 9.95 grams, Cinnabaris 0.5 gram.
Method for making: above ten simply, and except that Cinnabaris, Bulbus Allii, all the other are ground into fine powder altogether, sieves, with Cinnabaris, Bulbus Allii dispel poison, processing and porphyrize, with above-mentioned powder facing-up, sieves, and mixing is used water pill, the heavy 2.5g of per 10 balls.Promptly.
Embodiment 2
GUANGSUANZAO 9.95 grams, Radix Angelicae Sinensis 9.95 grams, Lignum Aquilariae Resinatum 9.95 grams, Herba Corydalis 9.95 grams, Semen Myristicae 9.95 grams, Fructus Phyllanthi 9.95 grams, Herba Veronicae Ciliatae 9.95 grams, Bulbus Allii 9.95 grams, Fructus Chebulae's 9.95 grams, dried Fructus Vitis viniferae 9.95 grams, Cinnabaris 0.5 gram.
Method for making: above ten simply, and except that Cinnabaris, Bulbus Allii, all the other are ground into fine powder altogether, sieves, with Cinnabaris, Bulbus Allii dispel poison, processing and porphyrize, with above-mentioned powder facing-up, sieves, and mixing directly incapsulates medicated powder, promptly.

Claims (2)

1, the medicine of treatment cardiovascular and cerebrovascular disease, it is characterized in that: it is made up of the component of following weight ratio: GUANGSUANZAO 6-12, Radix Angelicae Sinensis 6-12, Lignum Aquilariae Resinatum 6-12, Herba Corydalis 6-12, Semen Myristicae 6-12, Fructus Phyllanthi 6-12, Herba Veronicae Ciliatae 6-12, Bulbus Allii 6-12, Fructus Chebulae 6-12, dried Fructus Vitis viniferae 6-12, Cinnabaris 0.1-0.8.
2,, it is characterized in that pharmaceutical dosage form is pill or capsule according to the medicine of claim 1.
CN 01102281 2001-01-21 2001-01-21 Anshen pill-treating cardio-cerebral angiopathy Expired - Fee Related CN1129447C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01102281 CN1129447C (en) 2001-01-21 2001-01-21 Anshen pill-treating cardio-cerebral angiopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01102281 CN1129447C (en) 2001-01-21 2001-01-21 Anshen pill-treating cardio-cerebral angiopathy

Publications (2)

Publication Number Publication Date
CN1304771A CN1304771A (en) 2001-07-25
CN1129447C true CN1129447C (en) 2003-12-03

Family

ID=4652616

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01102281 Expired - Fee Related CN1129447C (en) 2001-01-21 2001-01-21 Anshen pill-treating cardio-cerebral angiopathy

Country Status (1)

Country Link
CN (1) CN1129447C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327268B (en) * 2008-06-03 2011-09-21 陈德顺 Oral chinese medicine for treating solar urticaria
CN102716347B (en) * 2012-06-29 2013-08-14 宋永心 Tibetan medicine for treating hypertension and preparation method thereof
CN102793860B (en) * 2012-09-07 2014-04-02 久美彭措 Tibetan medicine for treating cerebral thrombosis
CN104336262A (en) * 2014-11-16 2015-02-11 久美彭措 Insomnia-resistant substitute tea prepared by combining edible plants serving as components

Also Published As

Publication number Publication date
CN1304771A (en) 2001-07-25

Similar Documents

Publication Publication Date Title
CN1895620A (en) Chinese-medicinal composition for treating coronary heart disease
CN1305483C (en) Heart failure regulating Chinese medicine
CN102145128A (en) Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof
CN1140279C (en) Blood-cleaning pill
CN101843661A (en) Chinese medicament for treating angina
CN1129447C (en) Anshen pill-treating cardio-cerebral angiopathy
CN1733242A (en) Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same
CN1124856C (en) Pill for treating hemiplegia
CN103393749A (en) Traditional Chinese medicine for preventing and treating ischemic cardiovascular and cerebrovascular diseases
CN1823995A (en) New medicine for treating malignant tumour
CN102178798A (en) Preparation for reducing blood fat, preventing and treating cardiovascular and cerebrovascular diseases
CN101024048A (en) Medicine for treating heart disease
CN1990033A (en) Drug for treating hypertension, dense blood and arteriosclerosis
CN1164280C (en) Medicinal pill for taking care of heart health
CN1045892C (en) Chinese medicine Guanxintong for preventing and curing coronary heart disease and angina pectoris, and producing process thereof
CN1111054C (en) Medicine for treating apoplexy and its preparing process
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN1245197C (en) Chinese medicine preparation for treating coronary heart disease and viral myocarditis
CN101637556B (en) Pharmaceutical composition for treating heart disease and preparation method thereof
CN1140280C (en) Heart-nourishing Chinese angelica root pill
CN1660207A (en) Preparation of health care for reducing blood fat and cholesterol, and producing method
CN1850160A (en) Qidantongmai Tablet, and its preparing process
CN100339093C (en) Compound medicine for treating coronary heart disease and angina pectoris and its preparing process
CN102488769B (en) Diet pill
CN1853711A (en) Xinmaikangzhong Chinese medicinal composition and preparation thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: TASHI WANGA

Free format text: FORMER OWNER: BAIMA JIACUO

Effective date: 20130329

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 850000 LHASA, TIBET AUTONOMOUS REGION TO: 850000 NAGCHU PREFECTURE, TIBET AUTONOMOUS REGION

TR01 Transfer of patent right

Effective date of registration: 20130329

Address after: 850000 Lin profile Road No. 53 Tibet Nagqu County

Patentee after: Zahi Wan Fagafaga

Address before: Lhasa City, Tibet autonomous region 850000 Lin Kuo Foundation Hospital in the western part of North Tibet water reservoir Pharmaceutical Sales Department

Patentee before: Baima Jiacuo

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20031203

Termination date: 20180121

CF01 Termination of patent right due to non-payment of annual fee